Contact Supplier

Contact Supplier

To get in touch with Nordic BioSite supports first-ever joint BDSB/Nordic conference, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

Nordic BioSite supports first-ever joint BDSB/Nordic conference

news-releasesNordic BioSite AB
October 16th 2017

Täby, Sweden: – Scandinavia’s leading supplier of validated biotechnology products, Nordic BioSite AB (BioSite), will be a prominent presence at the first-ever joint BSDB/Nordic Conference on Developmental Biology and Regeneration in Stockholm later this month.

BioSite will attend the event as an invited sponsor and exhibitor, with an exhibition stand at Karolinska Institute featuring a range of the company’s latest research-based products and services.

MojoSort separation

Nordic BioSite Immunology Product Manager, Dr. Roger Festin, and Katie Burgess, Marketing Executive for BioSite partners Proteintech Group, will lead the BioSite team at the conference.

They will showcase a number of significant new offers, including the MojoSort™ magnetic cell separation system for the isolation and purification of cells from heterogeneous populations.

Other products and services featured in Stockholm will include Proteintech’s ELISA kits, validated antibodies from full-length antigens, and cGLP Histochemistry Services from BioSite’s Finnish Laboratory, BioSiteHisto.

Immunology research links

“It’s a great pleasure to be able to help to get this new event off the ground,” commented Roger Festin.

“It provides a significant new opportunity to deepen our links with our many customers in the immunology research community,” he said.

“Katie and I hope to spend a busy three days in helping researchers find out where to find exactly the right product to meet their needs,” Dr. Festin added.

About Nordic BioSite

Since the late 1990s, Nordic BioSite (BioSite) has become recognized as one of the pharma industry’s most innovative and customer-responsive supplier of high quality validated biotechnology products for research, diagnostics, immunology and molecular biology.

The company serves pharmaceutical, biotech, diagnostic and academic organizations with tens of thousands of different products in more than 30 different groups, ranging from antibodies to genetic vectors. These are sourced from selected manufacturers and laboratories in Europe, the Americas and Asia.

BioSite continuously introduces new products as a result of its own R&D, leveraged by close partnerships with manufacturers and feedback from customers.

Nordic BioSite’s company strapline, By Your Side™, defines a company ethos of partnering life science customers h, helping to find the right products and services to help reach chosen goals across the whole spectrum of biotech research areas.

BioSite also operates as a CRO through its Finnish-based cGLP laboratory, BioSiteHisto. This offers a wide range of leading-edge research-based custom laboratory services including histology, immunochemistry, in vitro research and testing, antibody optimization, antibody conjugation and predesigned adenylated linkers for Next Generation Sequencing (NGS).

About Joint BSDB/Nordic conference 2017

The first BSDB/Nordic conference on ‘Developmental Biology and Regeneration’ is jointly hosted by the British and four Nordic Societies for Developmental Biology.

The purpose of this international meeting is to gather a wide range of experts to showcase their most recent findings, and to discuss scientific as well as technological advances in the fields of development and regeneration.

The conference is a three-day event opening October 25 at Aula Medica, Karolinska Institute, in the Swedish capital, Stockholm, with a program covering a broad range of subjects, including animal and plant development, regeneration and stem cell sciences.

The event is organised by the Faculty of Medicine at Lund University with ore information available at: https://www.med.lu.se/bsdbnordic2017conference

Contact Nordic BioSite AB

Simply fill out the form below to contact Nordic BioSite AB now.

Send Nordic BioSite AB a Message